Skip to main content
logo
Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.42
+0.12 (0.78%)
At close: Feb 13, 2026, 4:00 PM EST
15.72
+0.30 (1.95%)
After-hours: Feb 13, 2026, 5:03 PM EST

Revenue by Product

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Recombinant Human C1 Esterase Inhibitor
226.91M
Recombinant Human C1 Esterase Inhibitor Growth
15.98%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
221.17M
United States Growth
16.17%
Europe and Rest of World
5.74M